Growth Metrics

Amdocs (DOX) Cash & Equivalents (2016 - 2025)

Amdocs (DOX) has disclosed Cash & Equivalents for 17 consecutive years, with $325.0 million as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents fell 6.09% to $325.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $325.0 million through Sep 2025, down 6.09% year-over-year, with the annual reading at $325.0 million for FY2025, 6.09% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $325.0 million at Amdocs, down from $346.1 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $709.1 million in Q3 2021, with the low at $325.0 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $494.7 million, with a median of $520.1 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents plummeted 33.46% in 2024, then dropped 6.09% in 2025.
  • Over 5 years, Cash & Equivalents stood at $709.1 million in 2021, then fell by 19.14% to $573.4 million in 2022, then dropped by 9.3% to $520.1 million in 2023, then tumbled by 33.46% to $346.1 million in 2024, then decreased by 6.09% to $325.0 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $325.0 million, $346.1 million, and $520.1 million for Q3 2025, Q3 2024, and Q3 2023 respectively.